Recovery from diabetes in mice by β cell regeneration

Journal of Clinical Investigation

Volumn 117, Issue 9, 2007, Pages 2553-2561

  Nir, Tomer ^a   Melton, Douglas A ^b   Dor, Yuval ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; DOXYCYCLINE; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; CONVALESCENCE; CYTOARCHITECTURE; DYNAMICS; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; CELL PROLIFERATION; CELL SHAPE; DIABETES MELLITUS; IMMUNOSUPPRESSIVE AGENTS; INSULIN-SECRETING CELLS; MICE; MICE, TRANSGENIC; REGENERATION;

EID: 34848887156     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32959     Document Type: Article

References (55)

1. Rood, P.P., et al. 2006. Facilitating physiologic self-regeneration: a step beyond islet cell replacement. Pharm. Res. 23:227-242.
2. Parsons, J.A., Brelje, T.C., and Sorenson, R.L. 1992. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology. 130:1459-1466.
3. Parsons, J.A., Bartke, A., and Sorenson, R.L. 1995. Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones. Endocrinology. 136:2013-2021.
4. Gupta, R.K., et al. 2007. Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha. Genes Dev. 21:756-769.
5. Maclean, N., and Ogilvie, R.F. 1955. Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes. 4:367-376.
6. Butler, A.E., et al. 2003. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 52:102-110.
7. Kulkarni, R.N., et al. 2004. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J. Clin. Invest. 114:828-836. doi:10.1172/JCI200421845.
8. Flier, S.N., Kulkarni, R.N., and Kahn, C.R. 2001. Evidence for a circulating islet cell growth factor in insulin-resistant states. Proc. Natl. Acad. Sci. U. S. A. 98:7475-7480.
9. Herold, K.C., et al. 2005. A single course of anti-CD3 monoclonal antibody hOKT3gamma1 (Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes. 54:1763-1769.
10. Herold, K.C., et al. 2002. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346:1692-1698.
11. Bresson, D., et al. 2006. Anti-CD3 and nasal pro-insulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J. Clin. Invest. 116:1371-1381. doi:10.1172/JCI27191.
12. Voltarelli, J.C., et al. 2007. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 297:1568-1576.
13. Chatenoud, L., Thervet, E., Primo, J., and Bach, J.F. 1994. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 91:123-127.
14. Kodama, S., Kuhtreiber, W., Fujimura, S., Dale, E.A., and Faustman, D.L. 2003. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science. 302:1223-1227.
15. Nishio, J., et al. 2006. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science. 311:1775-1778.
16. Chong, A.S., et al. 2006. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Science. 311:1774-1775.
17. Suri, A., et al. 2006. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science. 311:1778-1780.
18. Melton, D.A. 2006. Reversal of type 1 diabetes in mice. N. Engl. J. Med. 355:89-90.
19. Halban, P.A. 2004. Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine. Nat. Cell Biol. 6:1021-1025.
20. Bonner-Weir, S., and Weir, G.C. 2005. New sources of pancreatic beta-cells. Nat. Biotechnol. 23:857-861.
21. Dor, Y., Brown, J., Martinez, O.I., and Melton, D.A. 2004. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 429:41-46.
22. Heit, J.J., Karnik, S.K., and Kim, S.K. 2006. Intrinsic regulators of pancreatic beta-cell proliferation. Annu. Rev. Cell Dev. Biol. 22:311-338.
23. Milo-Landesman, D., et al. 2001. Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic beta cells controlled by the tet-on regulatory system. Cell Transplant. 10:645-650.
24. Eldor, R., et al. 2006. Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc. Natl. Acad. Sci. U. S. A. 103:5072-5077.
25. Lee, P., et al. 1998. Conditional lineage ablation to model human diseases. Proc. Natl. Acad. Sci. U. S. A. 95:11371-11376.
26. Yamaizumi, M., Mekada, E., Uchida, T., and Okada, Y. 1978. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell. 15:245-250.
27. Herrera, P.L. 2000. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development. 127:2317-2322.
28. Shapiro, A.M., et al. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238.
29. Ryan, E.A., et al. 2005. Five-year follow-up after clinical islet transplantation. Diabetes. 54:2060-2069.
30. Truong, W., Lakey, J.R., Ryan, E.A., and Shapiro, A.M. 2005. Clinical islet transplantation at the University of Alberta - the Edmonton experience. Clin. Transpl. 0:153-172.
31. Shapiro, A.M., et al. 2006. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355:1318-1330.
32. Molano, R.D., et al. 2003. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. Transplantation. 75:1812-1819.
33. Lopez-Talavera, J.C., et al. 2004. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology. 145:467-474.
34. Meier, J.J., et al. 2006. Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia. 49:1838-1844.
35. Meier, J.J., Bhushan, A., Butler, A.E., Rizza, R.A., and Butler, P.C. 2005. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia. 48:2221-2228.
36. Sherry, N.A., et al. 2006. Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes. 55:3238-3245.
37. Eizirik, D.L., Spencer, P., and Kisby, G.E. 1996. Potential role of environmental genotoxic agents in diabetes mellitus and neurodegenerative diseases. Biochem. Pharmacol. 51:1585-1591.
38. Kushner, J.A., et al. 2002. Pdx1 restores beta cell function in Irs2 knockout mice. J. Clin. Invest. 109:1193-1201. doi:10.1172/JCI200214439.
39. Georgia, S., and Bhushan, A. 2004. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J. Clin. Invest. 114:963-968. doi:10.1172/JCI200422098.
40. Teta, M., Rankin, M.M., Long, S.Y., Stein, G.M., and Kushner, J.A. 2007. Growth and regeneration of adult Beta cells does not involve specialized progenitors. Dev. Cell. 12:817-826.
41. Brennand, K., Huangfu, D., and Melton, D. 2007. All beta cells contribute equally to islet growth and maintenance. PLoS Biol. 5:e163.
42. Gershengorn, M.C., et al. 2004. Epithelial-tomesenchymal transition generates proliferative human islet precursor cells. Science. 306:2261-2264.
43. Ouziel-Yahalom, L., et al. 2006. Expansion and redifferentiation of adult human pancreatic islet cells. Biochem. Biophys. Res. Commun. 341:291-298.
44. Weinberg, N., Ouziel-Yahalom, L., Knoller, S., Efrat, S., and Dor, Y. 2007. Lineage tracing evidence for in vitro dedifferentiation, but rare proliferation, of mouse pancreatic {beta} cells. Diabetes. 56:1299-1304.
45. Atouf, F., et al. 2007. No evidence for mouse pancreatic beta-cell epithelial-mesenchymal transition in vitro. Diabetes. 56:699-702.
46. Chase, L.G., Ulloa-Montoya, F., Kidder, B.L., and Verfaillie, C.M. 2007. Islet-derived fibroblast-like cells are not derived via epithelial-mesenchymal transition from Pdx-1 or insulin-positive cells. Diabetes. 56:3-7.
47. Morton, R.A., Geras-Raaka, E., Wilson, L.M., Raaka, B.M., and Gershengorn, M.C. 2007. Endocrine precursor cells from mouse islets are not generated by epithelial-to-mesenchymal transition of mature beta cells. Mol. Cell. Endocrinol. 270:87-93.
48. Ryoo, H.D., Gorenc, T., and Steller, H. 2004. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev. Cell. 7:491-501.
49. Weir, G.C., and Bonner-Weir, S. 2004. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes. 53(Suppl. 3):S16-S21.
50. Teta, M., Long, S.Y., Wartschow, L.M., Rankin, M.M., and Kushner, J.A. 2005. Very slow turnover of beta-cells in aged adult mice. Diabetes. 54:2557-2567.
51. Michalopoulos, G.K., and DeFrances, M.C. 1997. Liver regeneration. Science. 276:60-66.
52. Jensen, J.N., et al. 2005. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology. 128:728-741.
53. Rother, K.I., and Harlan, D.M. 2004. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J. Clin. Invest. 114:877-883. doi:10.1172/JCI200423235.
54. Heit, J.J., et al. 2006. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature. 443:345-349.
55. Lobe, C.G., et al. 1999. Z/AP, a double reporter for cre-mediated recombination. Dev. Biol. 208:281-292.